Cargando…

MiRNA-22 inhibits oncogene galectin-1 in hepatocellular carcinoma

Hepatic stellate cells (HSCs) induce immune privilege and promote hepatocellular carcinoma (HCC) by suppressing the immune system. On the other hand, galectin-1 and miRNA-22 (miR-22) are dysregulated in HCC and serve as prognostic indicators for patients. In this study, therefore, we measured galect...

Descripción completa

Detalles Bibliográficos
Autores principales:	You, Yu, Tan, Jia-Xin, Dai, Hai-Su, Chen, Hao-Wei, Xu, Xue-Jun, Yang, Ai-Gang, Zhang, Yu-Jun, Bai, Lian-Hua, Bie, Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302976/ https://www.ncbi.nlm.nih.gov/pubmed/27494859 http://dx.doi.org/10.18632/oncotarget.10981

Ejemplares similares

EZH2 promotes hepatocellular carcinoma progression through modulating miR-22/galectin-9 axis
por: Chen, Shaofei, et al.
Publicado: (2018)

Overexpression of Galectin-1 and Galectin-3 in hepatocellular carcinoma
por: Setayesh, Tahereh, et al.
Publicado: (2020)

The heterogeneity of plasma miRNA profiles in hepatocellular carcinoma patients and the exploration of diagnostic circulating miRNAs for hepatocellular carcinoma
por: Bai, Xue, et al.
Publicado: (2019)

Predicting miRNA targets for hepatocellular carcinoma with an integrated method
por: Shi, Yi-Hua, et al.
Publicado: (2020)

C-Myc-dependent repression of two oncogenic miRNA clusters contributes to triptolide-induced cell death in hepatocellular carcinoma cells
por: Li, Shu-Guang, et al.
Publicado: (2018)

Prediction and preliminary validation of oncogene regulation by miRNAs
por: Koscianska, Edyta, et al.
Publicado: (2007)

miRNAs versus oncogenes: the power of social networking
por: Malumbres, Marcos
Publicado: (2012)

An Insight into miR-1290: An Oncogenic miRNA with Diagnostic Potential
por: Guz, Małgorzata, et al.
Publicado: (2022)

miR-208-3p promotes hepatocellular carcinoma cell proliferation and invasion through regulating ARID2 expression
por: Yu, Peng, et al.
Publicado: (2015)

Modulation of oncogenic miRNA biogenesis using functionalized polyamines
por: Staedel, Cathy, et al.
Publicado: (2018)

Screening and preliminary validation of miRNAs with the regulation of hTERT in colorectal cancer
por: QIN, YU-ZHOU, et al.
Publicado: (2015)

ETS Proto-Oncogene 1-activated muskelin 1 antisense RNA drives the malignant progression of hepatocellular carcinoma by targeting miR-22-3p to upregulate ETS Proto-Oncogene 1
por: Pan, Guozheng, et al.
Publicado: (2022)

Uncovering miRNAs involved in crosstalk between nutrient deficiencies in Arabidopsis
por: Liang, Gang, et al.
Publicado: (2015)

Diagnostic and prognostic value of circulating miRNA‐499 and miRNA‐22 in acute myocardial infarction
por: Wang, Xiaoqing, et al.
Publicado: (2020)

miRNA-22 as a Candidate Diagnostic Biomarker for Coronary Slow Flow
por: Chen, Tong, et al.
Publicado: (2020)

The oncogene Musashi1 encodes novel miRNAs in breast cancer
por: Lachinani, Liana, et al.
Publicado: (2023)

An Immunocompetent Environment Unravels the Proto-Oncogenic Role of miR-22
por: Centomo, Maria Laura, et al.
Publicado: (2022)

miRNA-22 Upregulates Mtf1 in Dorsal Horn Neurons and Is Essential for Inflammatory Pain
por: Hao, Ling-Yun, et al.
Publicado: (2022)

Galectin-3 not Galectin-9 as a candidate prognosis marker for hepatocellular carcinoma
por: Kong, Fei, et al.
Publicado: (2020)

Evaluation of miRNA-7, miRNA-10 and miRNA-21 as diagnostic non-invasive biomarkers of hepatocellular carcinoma
por: Elabd, Walaa K., et al.
Publicado: (2023)

Increased miRNA-22 expression sensitizes esophageal squamous cell carcinoma to irradiation
por: Wang, Xiao-chun, et al.
Publicado: (2013)

A miRNA-regulatory network explains how dysregulated miRNAs perturb oncogenic processes across diverse cancers
por: Plaisier, Christopher L., et al.
Publicado: (2012)

Smad3-related miRNAs regulated oncogenic TRIB2 promoter activity to effectively suppress lung adenocarcinoma growth
por: Zhang, Yan-Xia, et al.
Publicado: (2016)

miR-454 functions as an oncogene by inhibiting CHD5 in hepatocellular carcinoma
por: Yu, Lei, et al.
Publicado: (2015)

Author Correction: Uncovering miRNAs involved in crosstalk between nutrient deficiencies in Arabidopsis
por: Liang, Gang, et al.
Publicado: (2020)

miR-372 down-regulates the oncogene ATAD2 to influence hepatocellular carcinoma proliferation and metastasis
por: Wu, Gang, et al.
Publicado: (2014)

Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma
por: Zhao, Ling-Hao, et al.
Publicado: (2016)

Novel oncogenic and chemoresistance-inducing functions of resistin in ovarian cancer cells require miRNAs-mediated induction of epithelial-to-mesenchymal transition
por: Qiu, Ling, et al.
Publicado: (2018)

Expression and role of oncogenic miRNA-224 in esophageal squamous cell carcinoma
por: He, Xiaoyan, et al.
Publicado: (2015)

miRNA-218 targets multiple oncogenes and is a therapeutic target for osteosarcoma
por: Sato, Kentaro, et al.
Publicado: (2022)

Oncogenic Role of miRNA in Environmental Exposure to Plasticizers: A Systematic Review
por: Ferrante, Margherita, et al.
Publicado: (2021)

MicroRNA 320, an Anti-Oncogene Target miRNA for Cancer Therapy
por: Liang, Yuanyuan, et al.
Publicado: (2021)

MiR-486-5p negatively regulates oncogenic NEK2 in hepatocellular carcinoma
por: Fu, Shun-Jun, et al.
Publicado: (2017)

Interaction of the Oncofetal Thomsen–Friedenreich Antigen with Galectins in Cancer Progression and Metastasis
por: Sindrewicz, Paulina, et al.
Publicado: (2016)

Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma
por: Jiang, Shan-Shan, et al.
Publicado: (2014)

The Potential Role of CDH1 as an Oncogene Combined With Related miRNAs and Their Diagnostic Value in Breast Cancer
por: Xie, Dan, et al.
Publicado: (2022)

Potential plasma biomarkers: miRNA-29c, miRNA-21, and miRNA-155 in clinical progression of Hepatocellular Carcinoma patients
por: Ratnasari, Neneng, et al.
Publicado: (2022)

The Janus-faced Nature of miR-22 in Hematopoiesis: Is It an Oncogenic Tumor Suppressor or Rather a Tumor-Suppressive Oncogene?
por: Wurm, Alexander Arthur, et al.
Publicado: (2017)

miRConnect 2.0: identification of oncogenic, antagonistic miRNA families in three human cancers
por: Hua, Youjia, et al.
Publicado: (2013)

Potential miRNAs for miRNA-Based Therapeutics in Breast Cancer
por: Wong, Jun Sheng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ipsil0u8o55u8516haq7d0ldhd